DrugPatentWatch Database Preview
Investigational Drug Information for AF-219
Email this page to a colleague
What is the drug development status for AF-219?
AF-219 is an investigational drug.
There have been 15 clinical trials for AF-219.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 29th 2012.
The most common disease conditions in clinical trials are Cough, Fibrosis, and Pulmonary Fibrosis. The leading clinical trial sponsors are Afferent Pharmaceuticals, Inc., Celerion, and [disabled in preview].
There are twenty-five US patents protecting this investigational drug and two hundred and thirty-three international patents.
Summary for AF-219
| US Patents | 25 |
| International Patents | 233 |
| US Patent Applications | 86 |
| WIPO Patent Applications | 30 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 2 (2012-03-29) |
| Vendors | 31 |
Recent Clinical Trials for AF-219
| Title | Sponsor | Phase |
|---|---|---|
| A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations | Afferent Pharmaceuticals, Inc. | Phase 1 |
| An 8-Week Refractory Chronic Cough Study (MK-7264-021) | Afferent Pharmaceuticals, Inc. | Phase 2 |
| A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012) | Afferent Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for AF-219
Top disease conditions for AF-219
Top clinical trial sponsors for AF-219
US Patents for AF-219
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AF-219 | ⤷ Sign up for a Free Trial | Selective P2X3 modulators | BELLUS HEALTH COUGH INC. (Laval, Quebec, CA) NEOMED INSTITUTE (Montreal, Quebec, CA) | ⤷ Sign up for a Free Trial |
| AF-219 | ⤷ Sign up for a Free Trial | Methods and compositions for treating diseases and conditions | Afferent Pharmaceuticals, Inc. (San Mateo, CA) | ⤷ Sign up for a Free Trial |
| AF-219 | ⤷ Sign up for a Free Trial | JAK inhibitors containing a 4-membered heterocyclic amide | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AF-219
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AF-219 | Australia | AU2018342751 | 2037-09-18 | ⤷ Sign up for a Free Trial |
| AF-219 | Canada | CA3076150 | 2037-09-18 | ⤷ Sign up for a Free Trial |
| AF-219 | China | CN111601601 | 2037-09-18 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
